SCHEMBL17850340

SCHEMBL17850340

CO[C@@H]1OC(COC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C1OC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
PTPN1 P18031 4/20 0.52
USP2 O75604 2/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
POLB P06746 1/20 0.51
PAX8 Q06710 1/20 0.48
LMNA P02545 2/20 0.48
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
TMPRSS2 O15393 1/20 0.47
PDE5A O76074 1/20 0.47
HMGCR P04035 1/20 0.47
CYP1A2 P05177 1/20 0.47
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
HSPD1 P10809 1/20 0.47
CYP2C9 P11712 1/20 0.47
CA6 P23280 1/20 0.47
TBXAS1 P24557 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850321 1.00 TSHR (0.55) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL13447782 1.00 TSHR (0.55) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL22022529 0.99 TSHR (0.53) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL17850298 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL22455860 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL13271795 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL20730007 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL13250762 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL14405192 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1
SCHEMBL18068236 0.95 PTPN1 (0.56) TSHRPTPN1USP2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034510-A1 OLIGONUCLEOTIDES COMPRISING A C5-MODIFIED PYRIMIDINE Alnylam Pharmaceuticals Inc. (US) 2016-06-22 EP disclosed